TBLD vs THQ

Thornburg Income Builder Opport vs Tekla Healthcare Opportunies Fu — Valuation Comparison 2026

TBLD

Asset Management
Thornburg Income Builder Opport
Quality
1.7
out of 10
Value Trap
Price
$22.50
Last close
Models
6/13
Active
VS

THQ

Asset Management
Tekla Healthcare Opportunies Fu
Quality
1.8
out of 10
Value Trap
Price
$18.61
Last close
Models
6/13
Active

Model-by-Model Comparison

ModelType TBLD Fair ValueTBLD Upside THQ Fair ValueTHQ Upside
Bayesian DCF Intrinsic $5.96 -73.5% $4.93 -73.5%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $13.24 -39.3% $18.88 +1.5%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for TBLD vs THQ — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TBLD vs THQ — Which Stock Is More Undervalued?

THQ scores higher with a 1.8/10 quality rating vs TBLD's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Thornburg Income Builder Opport (TBLD) and Tekla Healthcare Opportunies Fu (THQ) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TBLD currently trades at $22.50 with a QOC of 1.7/10, while THQ trades at $18.61 with a QOC of 1.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).